<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We serially measured the plasma thrombomodulin (TM) levels in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) patients and assessed them clinically </plain></SENT>
<SENT sid="1" pm="."><plain>The patients who responded to medical treatment experienced a decrease in plasma TM levels </plain></SENT>
<SENT sid="2" pm="."><plain>Patients who developed exacerbations of SLE, thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> or <z:mp ids='MP_0005048'>thrombosis</z:mp>, displayed increased plasma TM levels </plain></SENT>
<SENT sid="3" pm="."><plain>There was no significant difference between the plasma TM levels of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>-positive (LAC-positive) patients and the LAC-negative patients or between the plasma TM levels of the anticardiolipin antibody-positive (aCL-positive) patients and the aCL-negative patients </plain></SENT>
<SENT sid="4" pm="."><plain>While LAC and aCL titers did not always coincide with improvement in the patients' clinical course or with aggravation of the disease, the TM values correlated well with the patients' clinical condition </plain></SENT>
<SENT sid="5" pm="."><plain>Plasma TM values may be used to evaluate disease activity and may predict the occurrence of <z:mp ids='MP_0005048'>thrombosis</z:mp> in SLE </plain></SENT>
</text></document>